These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23154871)

  • 1. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
    Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
    Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.
    Schwarze V; Marschner C; Völckers W; Grosu S; Negrão de Figueiredo G; Rübenthaler J; Clevert DA
    J Int Med Res; 2020 Jun; 48(6):300060520930151. PubMed ID: 32529869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
    Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
    Huang Y; Wang Y; Liu L; Zhu L; Qiu Y; Zuo D; Lu X; Dong Y; Jung EM; Wang W
    Clin Hemorheol Microcirc; 2023; 83(4):409-420. PubMed ID: 36683500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Contrast-Enhanced Ultrasonography Combined With LR-M Classification Criteria for Differentiating Malignant Liver Nodules at High Risk for Hepatocellular Carcinoma.
    Qiu S; Ding J; Wang Y; Zhou H; Zhao L; Zhao L; Zhou Y; Fu Y; Jing X
    Ultrasound Med Biol; 2024 Jul; 50(7):1028-1033. PubMed ID: 38632025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
    Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
    J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic performance of contrast-enhanced ultrasound (CEUS) for evaluating hepatocellular carcinoma (HCC) juxtaposed to MRI findings; a retrospective single-center analysis of 292 patients.
    Schwarze V; Marschner C; Völckers W; de Figueiredo GN; Rübenthaler J; Clevert DA
    Clin Hemorheol Microcirc; 2020; 76(2):155-160. PubMed ID: 32925017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of contrast enhanced ultrasound (CEUS) of hepatocellular carcinoma in patients with cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS).
    Chang J; Dumitrache A; Böhling N; Abu-Omar J; Meyer C; Strobel D; Luetkens J; Luu AM; Rockstroh J; Strassburg CP; Trebicka J; Gonzalez-Carmona MA; Marinova M; Praktiknjo M
    Sci Rep; 2020 Nov; 10(1):20682. PubMed ID: 33244180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential application of dynamic contrast enhanced ultrasound in predicting microvascular invasion of hepatocellular carcinoma.
    Dong Y; Qiu Y; Yang D; Yu L; Zuo D; Zhang Q; Tian X; Wang WP; Jung EM
    Clin Hemorheol Microcirc; 2021; 77(4):461-469. PubMed ID: 33459703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Enhanced Ultrasound Findings and Differential Diagnosis of Hepatic Epithelioid Angiomyolipoma Compared with Hepatocellular Carcinoma.
    Huang Z; Wu X; Li S; Li K
    Ultrasound Med Biol; 2020 Jun; 46(6):1403-1411. PubMed ID: 32165015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Comparison of Prediction Models Based on Sonovue- and Sonazoid-Enhanced Ultrasound for Pathologic Grade and Microvascular Invasion in Hepatocellular Carcinoma.
    Zhang R; Li D; Chen Y; Xu W; Zhou W; Lin M; Xie X; Xu M
    Ultrasound Med Biol; 2024 Mar; 50(3):414-424. PubMed ID: 38155069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement patterns of small hepatocellular carcinoma (≤ 30 mm) on contrast-enhanced ultrasound: Correlation with clinicopathologic characteristics.
    Fan PL; Ding H; Mao F; Chen LL; Dong Y; Wang WP
    Eur J Radiol; 2020 Nov; 132():109341. PubMed ID: 33069987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study.
    Dong Y; Wang WP; Lee WJ; Meloni MF; Clevert DA; Chammas MC; Tannapfel A; Forgione A; Piscaglia F; Dietrich CF
    Ultrasound Med Biol; 2022 Sep; 48(9):1797-1805. PubMed ID: 35710501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Features of Fibrolamellar Hepatocellular Carcinoma with Contrast-Enhanced Ultrasound.
    Dong Y; Wang WP; Mao F; Zhang Q; Yang D; Tannapfel A; Meloni MF; Neye H; Clevert DA; Dietrich CF
    Ultraschall Med; 2021 Jun; 42(3):306-313. PubMed ID: 32102105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Contrast-enhanced Ultrasound Characteristics of Epithelioid and Classic Hepatic Angiomyolipoma: Comparison With Alpha-fetoprotein-negative Hepatocellular Carcinoma.
    Zou MH; Huang Q; Zou Q; Jiang Y; Ju JX; Zhou HC; Jiao J; Zheng RQ
    Ultrasound Med Biol; 2021 Mar; 47(3):446-453. PubMed ID: 33353786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size measurements of hepatocellular carcinoma: comparisons between contrast and two-dimensional ultrasound.
    Chen F; Wang F; Sun S; Zhu M; Liu Z
    BMC Gastroenterol; 2020 Nov; 20(1):390. PubMed ID: 33213375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of conventional ultrasound, contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging in assessing the size of breast cancer.
    Shi XQ; Dong Y; Tan X; Yang P; Wang C; Feng W; Lin Y; Qian L
    Clin Hemorheol Microcirc; 2022; 82(2):157-168. PubMed ID: 35723092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative hepatic perfusion modeling using DCE-MRI with sequential breathholds.
    Bultman EM; Brodsky EK; Horng DE; Irarrazaval P; Schelman WR; Block WF; Reeder SB
    J Magn Reson Imaging; 2014 Apr; 39(4):853-65. PubMed ID: 24395144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma.
    Lu XY; Jiang J; Chen S; Qiu YJ; Wang Y; Cheng J; Xu XL; Dong Y; Wang WP
    Eur J Radiol; 2024 Jun; 175():111439. PubMed ID: 38547743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.